App-Quantinova.ai

AMOUNT OF ALCOHOL HAS NO LONG-TERM EFFECT ON MORTALITY AFTER ALCOHOL SEPTAL ABLATION

Pieter A. Vriesendorp - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

PRE-TRANSPLANT CHEMOTHERAPY DOES NOT AFFECT POST TRANSPLANT OUTCOME IN PATIENTS UNDERGOING OHT FOR AL CARDIOMYOPATHY

Nitasha Sarswat - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

Cyclophosphamide

THE CLINICAL IMPACT OF ATRIAL FIBRILLATION IN PATIENTS WITH THE HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE

Alan Enriquez - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

HIGH PULMONARY ARTERY SYSTOLIC PRESSURE AND SHORTER DURATION OF CARDIOMYOPATHY PREDICT IMPROVEMENT IN RIGHT VENTRICULAR FUNCTION WITH CONTINUOUS FLOW LVAD

Rita A. Jermyn - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

BLEEDING AND THROMBOEMBOLIC EVENTS IN PATIENTS WITH A HEARTMATE II LEFT VENTRICULAR ASSIST DEVICE

Salman llana - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

Warfarin

THE MAGNITUDE OF CARDIOVASCULAR CHANGE IN CIRRHOTIC CARDIOMYOPATHY IN PREDICTING OF HEPATORENAL SYNDROME

Parichart Junpaparp - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Heart muscle disease

N/A

INCREMENTAL VALUE OF CYSTATIN C BEYOND CONVENTIONAL MARKERS OF RENAL FUNCTION FOR PREDICTING CLINICAL RESPONSE IN PATIENTS RECEIVING CARDIAC RESYNCHRONIZATION THERAPY: THE BIOCRT STUDY

Neal Chatterjee - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Vista

CARDIAC FUNCTION IS ENHANCED BY MINERALOCORTICOID RECEPTOR ANTAGONISTS (MRAS) DURING CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE SUPPORT

Omar Saeed - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

Angiotensin II

DIABETES CONFERS GREATER MORTALITY RISK IN ISCHEMIC VERSUS NONISCHEMIC HEART FAILURE PATIENTS IN THE BEST, DIG, AND SOLVD TRIALS

Suneet Nitin Purohit - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

Enalapril maleate

SALUTATORY ASSOCIATION OF ALCOHOL CONSUMPTION ON VENTRICULAR DIASTOLIC FUNCTION IN OBESE AND NONOBESE POPULATIONS

Mirza Nubair Ahmad - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

N/A

DIFFERING PATTERNS OF MYOSTATIN SIGNALING REGULATE HYPERTROPHY IN SEVERE AORTIC STENOSIS AND HYPERTROPHIC CARDIOMYOPATHY

Estibaliz Castillero - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Mecasermin

LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN TYPE 2 DIABETES IS MEDIATED BY ENDOTHELIAL DYSFUNCTION

Melissa Leung - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

N/A

IMPLICATIONS OF THE DISCREPANCY IN EJECTION FRACTION REPORTING BETWEEN ECHOCARDIOGRAPHY AND RADIONUCLIDE ANGIOGRAPHY IN A TERTIARY CARE HEART FUNCTION CLINIC

Katrina Elise Zefkic - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

PROGNOSTIC IMPACT OF FUNCTIONAL MITRAL REGURGITATION EARLY IMPROVEMENT IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY RECEIVING OPTIMAL MEDICAL TREATMENT

Davide Stolfo - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

FEMALE SEX, DYSPNEA AND HEART FAILURE PREDOMINATE AS NEGATIVE PREDICTORS OF HEALTH-RELATED QUALITY OF LIFE (HRQL) IN PATIENTS WITH CARDIOVASCULAR DISEASE

Paul Cremer - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

THE CORRELATION BETWEEN PERIPARTUM CARDIOMYOPATHY AND AUTOANTIBODIES AGAINST CARDIOVASCULAR RECEPTORS

Lin Zhang - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

COMPUTATIONAL MULTIVARIATE ANALYSES FOR PHASE-SPECIFIC BIOMARKER IDENTIFICATION IN NOVEL IN VIVO AND IN VITRO VIRAL MYOCARDITIS MODELS INDUCED BY CARDIOVIRUS

Fereidoon Shafiei - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

THE ROLE OF RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS AND ITS LIGAND HIGH MOBILITY GROUP BOX 1 IN AUTOIMMUNE MYOCARDITIS

Anna Bangert - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

SITES OF LATEST MECHANICAL ACTIVATION AS ASSESSED BY SPECT MYOCARDIAL PERFUSION IMAGING IN ISCHEMIC AND DILATED CARDIOMYOPATHY PATIENTS WITH LBBB

Xianhe Lin - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

EXTRACELLULAR MATRIX EXPANSION IS MORE STRONGLY ASSOCIATED WITH CARDIOVASCULAR OUTCOMES THAN LEFT VENTRICULAR MASS

Timothy C. Wong - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Filters

3340 Abstracts